טוען...
Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
The sites of targeted therapy are limited and need to be expanded. The FGF‐FGFR signalling plays pivotal roles in the oncogenic process, and FGF/FGFR inhibitors are a promising method to treat FGFR‐altered tumours. The VEGF‐VEGFR signalling is the most crucial pathway to induce angiogenesis, and inh...
שמור ב:
| הוצא לאור ב: | Cell Prolif |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8016646/ https://ncbi.nlm.nih.gov/pubmed/33655556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.13009 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|